Literature DB >> 1406654

Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis.

R Vassar1, M E Hutton, E Fuchs.   

Abstract

The induction of skin papillomas in mice can be divided into two different stages. Chemical initiation frequently elicits mutations in the Ha-ras gene, leading to the constitutive activation of ras. The second step, promotion, involves repetitive topical application of phorbol esters or wounding, leading to epidermal hyperproliferation and papilloma formation. We have found that overexpression of transforming growth factor alpha (TGF-alpha) in the basal epidermal layer of transgenic mice yielded papillomas directly upon wounding or 12-O-tetradecanoylphorbol-13-acetate treatment without the need for an initiator. Moreover, papillomas from TGF-alpha mice did not exhibit mutations in the Ha-ras gene. Interestingly, TGF-alpha acted synergistically with 12-O-tetradecanoylphorbol-13-acetate to enhance epidermal hyperproliferation. Our results demonstrate a central role for TGF-alpha overexpression in tumorigenesis and provide an important animal model for the study of skin tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1406654      PMCID: PMC360391          DOI: 10.1128/mcb.12.10.4643-4653.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

Authors:  G D Shipley; M R Pittelkow; J J Wille; R E Scott; H L Moses
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Stimulatory role of transforming growth factors in multistage skin carcinogenesis: possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin.

Authors:  G Fürstenberger; M Rogers; R Schnapke; G Bauer; P Höfler; F Marks
Journal:  Int J Cancer       Date:  1989-05-15       Impact factor: 7.396

4.  TGF alpha stimulates growth of skin papillomas by autocrine and paracrine mechanisms but does not cause neoplastic progression.

Authors:  E Finzi; A Kilkenny; J E Strickland; M Balaschak; T Bringman; R Derynck; S Aaronson; S H Yuspa
Journal:  Mol Carcinog       Date:  1988       Impact factor: 4.784

5.  Activation of ras oncogenes in chemically transformed BALB/MK-2 mouse keratinocytes.

Authors:  B E Weissman; M J Arboleda; K A Kimoto; M J MacDonald; R Ochiai; C J Der
Journal:  Mol Carcinog       Date:  1989       Impact factor: 4.784

6.  v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis.

Authors:  K Brown; M Quintanilla; M Ramsden; I B Kerr; S Young; A Balmain
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

7.  Induction of transforming growth factor-alpha expression in human keratinocytes by phorbol esters.

Authors:  M R Pittelkow; P B Lindquist; R T Abraham; R Graves-Deal; R Derynck; R J Coffey
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

8.  Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis.

Authors:  R J Akhurst; F Fee; A Balmain
Journal:  Nature       Date:  1988-01-28       Impact factor: 49.962

9.  Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts.

Authors:  J E Strickland; D A Greenhalgh; A Koceva-Chyla; H Hennings; C Restrepo; M Balaschak; S H Yuspa
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

10.  Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha.

Authors:  J Massagué
Journal:  J Cell Biol       Date:  1985-05       Impact factor: 10.539

View more
  21 in total

Review 1.  Transgenic models of pancreatic cancer.

Authors:  Andrew M Lowy
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 2.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

Review 3.  Epithelial stem cells, wound healing and cancer.

Authors:  Esther N Arwert; Esther Hoste; Fiona M Watt
Journal:  Nat Rev Cancer       Date:  2012-02-24       Impact factor: 60.716

4.  Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.

Authors:  Kaoru Kiguchi; Takuya Kitamura; Tricia Moore; Mohammad Rumi; Hsiang-Chun Chang; Devon Treece; Lynnsie Ruffino; Kevin Connolly; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-03

Review 5.  Modeling cutaneous squamous carcinoma development in the mouse.

Authors:  Phillips Y Huang; Allan Balmain
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

6.  Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential.

Authors:  Timothy J Patterson; Robert H Rice
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-14       Impact factor: 4.219

Review 7.  Transgenic mice and squamous multistage skin carcinogenesis.

Authors:  K Brown; A Balmain
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

8.  RasGRP1 transgenic mice develop cutaneous squamous cell carcinomas in response to skin wounding: potential role of granulocyte colony-stimulating factor.

Authors:  Federico R Diez; Ann A Garrido; Amrish Sharma; Courtney T Luke; James C Stone; Nancy A Dower; J Mark Cline; Patricia S Lorenzo
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

9.  Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.

Authors:  Jennifer L Gilmore; Jeffrey A Scott; Zhor Bouizar; Alex Robling; Sarah E Pitfield; David J Riese; John Foley
Journal:  Breast Cancer Res Treat       Date:  2007-09-20       Impact factor: 4.872

10.  Transgenic mouse model of malignant skin melanoma.

Authors:  B Mintz; W K Silvers
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.